n-3 Fatty acids anf mood: The devil is in the detail

British Journal of Nutrition

Volumn 99, Issue 2, 2008, Pages 221-223

  Richardson, Alex J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; NEUROLEPTIC AGENT; PLACEBO; POLYUNSATURATED FATTY ACID;

ANXIETY DISORDER; BIPOLAR DISORDER; BORDERLINE STATE; CLINICAL TRIAL; DEPRESSION; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; HUMAN; IMMUNOREGULATION; IMPULSE CONTROL DISORDER; MOOD DISORDER; NOTE; NUTRITIONAL SUPPORT; PRIMARY MEDICAL CARE; PSYCHIATRIC TREATMENT; RECOMMENDED DRUG DOSE; SCHIZOPHRENIA; SUICIDAL BEHAVIOR;

DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; FATTY ACIDS, OMEGA-3; HUMANS; META-ANALYSIS AS TOPIC; MOOD DISORDERS; TREATMENT OUTCOME;

EID: 38049125124     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507824123     Document Type: Note

References (15)

1. Peet M, Glen I & Horrobin DF (editors) (2006) Phospholipid Spectrum Disorders in Psychiatry and Neurology. Carnforth: Marius Press.
2. Vaddadi K (editor) (2006) Essential fatty acids and mental illness. In Int Rev Psychiatry, pp. 18, 81-186, Special Issue.
3. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE Jr, Marangell LB, Richardson AJ, Lake J & Stoll AL (2006) Omega-3 fatty acids: Eyidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954-1967.
4. Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA & Ness AR (2007) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial. Br J Nutr 99, 421-431.
5. Zanarini MC & Frankenburg FR (2003) Omega-3 fatty acid treatment of women with borderline personality disorder: A double-blind, placebo-controlled pilot study. Am J Psychiatry 160, 167-169.
6. Hallahan B, Hibbeln JR, Davis JM & Garland MR (2007) Omega-3 fatty acid supplementation in patients with recurrent self-harm: Single-centre double-blind randomised controlled trial. Br J Psychiatry 190 118-122.
7. Buydens-Branchey L & Branchey M (2006) n-3 Polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol 26, 661-665.
8. Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, Yazawa K, Kuwamori T & Kobayashi M (1996) The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest 97, 1129-1133.
9. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S & Lodi L (2005) Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35, 691-699.
10. Richardson AJ (2006) Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry 18, 155-171
11. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO & Palmblad J (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderateAAlzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63, 1402-1408.
12. Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D & Ness AR (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials. Am J Clin Nutr 84, 1308-1316.
13. Peet M & Horrobin DFA (2002) dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59, 913-919.
14. Peet M & Horrobin DFE-E-Multicentre-Study-Group (2002) A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatry Res 36, 7-18.
15. Recommendations for intake of polyunsaturated fatty acids in healthy adults ISSFAL Policy Statement 3, June Meeting, Brighton (www.issfal.org.uk/)